Brief: HLS Therapeutics Becomes Exclusive Canadian Distributor For Mycare Insite Point-Of-Care Device
01/06/2020 11:35
June 1 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS - HAS BECOME EXCLUSIVE CANADIAN
DISTRIBUTOR FOR
MYCARE INSITE POINT-OF-CARE DEVICE
* HLS THERAPEUTICS - HAS BECOME EXCLUSIVE CANADIAN
DISTRIBUTOR FOR
MYCARE RELATED LINE OF DIAGNOSTIC TESTS FROM SALADAX BIOMEDICAL
Source text for Eikon: ID:nCNWLp3WTa
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group